Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5.
- Resource Type
- Article
- Source
- Cancer Science; Dec2023, Vol. 114 Issue 12, p4511-4520, 10p
- Subject
- Language
- ISSN
- 13479032